LysSYL‐Loaded pH‐Switchable Self‐Assembling Peptide Hydrogels Promote Methicillin‐Resistant Staphylococcus Aureus Elimination and Wound Healing Authors: He Liu, Xuemei Wei, Huagang Peng, Yi Yang, Zhen Hu, Yifan Rao, Zhefen Wang, Jianxiong Dou, Xiaonan Huang, Qiwen Hu, Li Tan, Yuting Wang, Juan Chen, Lu Liu, Yuhua Yang, Jianghong Wu, Xiaomei Hu, Shuguang Lu, Weilong Shang, Xiancai Rao Published: 2024 ABSTRACT Abstract Staphylococcus aureus (S. aureus), especially methicillin‐resistant S. aureus (MRSA), causes wound infections, whose treatment remains a clinical challenge. Bacterium‐infected wounds often create acidic niches with a pH 4.5–6.5. Endolysin LysSYL, which is derived from phage SYL, shows promise as an antistaphylococcal agent. However, endolysins generally exhibit instability and possess low bioavailability in acidic microenvironments. Here, an array of self‐assembling peptides is designed, and peptide L5 is screened out based on its gel formation property and bioavailability. L5 exerted a pH‐switchable antimicrobial effect (pH 5.5) and formed biocompatible hydrogels at neutral pH (pH 7.4). The LysSYL‐loaded L5 can assemble L5@LysSYL hydrogels, increase thermal stability, and exhibit the slow‐release effect of LysSYL. Effective elimination of S. aureus is achieved by L5@LysSYL through bacterial membrane disruption and cell separation inhibition. Moreover, L5@LysSYL hydrogels exhibit great potential in promoting wound healing in a mouse wound model infected by MRSA. Furthermore, L5@LysSYL hydrogels are safe and can decrease the cytokine levels and increase the number of key factors for vessel formation, which contribute to wound healing. Overall, the self‐assembling L5@LysSYL can effectively clean MRSA and promote wound healing, which suggests its potential as a pH‐sensitive wound dressing for the management of wound infections.Keywords: endolysins, peptide hydrogels, pH‐sensitive, self‐organizing, Staphylococcus aureus (S. aureus), wound infections Introduction The extensive use of antibiotics has led to the emergence of antimicrobial resistance (AMR), which seriously threatens the health of human beings.[ 1 ] However, the development of new antibiotics lags far behind the evolution of drug‐resistant bacteria.[ 2 ] The prominent human pathogen Staphylococcus aureus (S. aureus) can cause various infections, which range from wound infection to serious pneumonia, osteomyelitis, and sepsis.[ 3 ] Methicillin‐resistant S. aureus (MRSA) was first recognized in 1961, and it has become a widespread community pathogen globally.[ 4 ] Skin and soft tissue infections (SSTIs) can be mostly attributed to hypervirulent community‐acquired MRSA, and the treatment of SSTIs caused by MRSA is costly and challenging.[ 5 , 6 ] Skin wound healing is a crucial biological process that transpires after skin injury; it depends on complex overlapping phases, including hemostasis, inflammation, proliferation, and remodeling.[ 7 ] Bacterial colonization and biofilm formation at wound sites are major factors that delay the healing process, and they increase the risk of pathogen dissemination in the body.[ 7 , 8 ] Moreover, wound contamination by bacteria, such as MRSA, can induce the production of excess amounts of inflammatory cytokines, stall the inflammation phase, and promote chronic wound formation during incomplete bacterial elimination.[ 8 , 9 ] Importantly, bacterial invaders often produce metabolites, such as acetic acid, lactic acid, and malic acid, and create an acidic microenvironment with pH 4.5–6.5.[ 10 , 11 , 12 ] However, most antimicrobial agents, including antimicrobial peptides, exhibit low activities in such acidic conditions.[ 13 ] Wound dressings such as gauze, polymer bandages, and cotton wool are commonly used in wound care, but they fail to prevent bacterial infections; in addition, frequent replacement wound dressings can cause damage to regenerative tissues.[ 14 ] Therefore, new wound dressings with excellent antibacterial, anti‐inflammation, and wound‐healing activities must be developed. Endolysins refer to phage‐encoded peptidoglycan hydrolases that can directly target chemical bonds in peptidoglycan and rapidly lyse the cell wall of Gram‐positive bacteria with missing outer membranes.[ 15 ] Endolysins exhibit a fast and strong bactericidal activity, contribute to effective biofilm elimination, and exhibit a low possibility of resistance development, which indicates their potential as antibiotic alternatives, especially when dealing with AMR.[ 3 , 15 ] Endolysin‐based candidate drugs, such as P128 and N‐Rephasin SAL200, are undergoing phases II and IIa clinic trials, respectively, for the treatment of S. aureus bacteriemia.[ 3 ] However, endolysins are usually unstable, easily influenced by various microenvironments, and exhibit low bioavailability and short in vivo half‐life, which limit their development and clinical applications.[ 16 , 17 ] The encapsulation technique has been considered a critical strategy for advanced endolysin applications.[ 15 , 16 ] However, the creation of a suitable delivery system for the successful delivery of certain endolysins remains a challenge. Hydrogels have been widely used in biomedical fields, such as tissue engineering and drug delivery.[ 18 ] These well‐developed biomaterials possess a 3D cross‐linked polymer network that enables them to incorporate diverse antimicrobial agents into their gel matrix and improve drug bioavailability.[ 19 , 20 ] In the field of hydrogels, peptide‐based supramolecules attract growing research interests due to their desirable biocompatibility, high bioactivity, intelligent sensing, and flexible tunability.[ 18 , 21 ] Meanwhile, peptides can be easily obtained using a solid‐phase peptide synthesizer.[ 22 ] In addition, amphipathic peptides can be organized into various micro and nanostructures through the adjustment of their self‐assembly parameters.[ 9 , 18 , 21 ] Moreover, self‐assembling peptide hydrogels exhibit a rapid and sensitive response to diverse stimulations, such as temperature, pH, enzymes, and ionic strength, which modulate their properties or behaviors in disease treatment.[ 19 , 21 ] The generation of pH‐sensitive peptide hydrogels has attracted considerable attention due to the variable acidity of pathological niches, where peptides form gels and are dissolved to attain the controllable and targeted delivery of drugs, which differ from that of healthy tissues.[ 18 , 23 ] In the present study, a series of pH‐responsive self‐assembling peptides were designed and synthesized in terms of a bacterium‐infected wound environment (pH 4.5–6.5). A peptide termed L5 was screened out for the delivery of endolysin LysSYL, which is derived from the lytic phage SYL targeting MRSA XN108.[ 3 ] L5 peptide alone can self‐assemble to form hydrogels under neutral conditions (pH 7.4) and disassemble to exert a broad‐spectrum antimicrobial activity in acidic environments (pH 5.5). After the encapsulation of LysSYL, the supramolecular L5@LysSYL hydrogels exhibited a sustained‐release effect and increased stability and bioavailability of LysSYL. Moreover, L5@LysSYL revealed the elimination of MRSA associated with bacterial membrane disruption and excellent and safe in vivo wound healing capabilities. As the first‐reported peptide‐based endolysin hydrogel system (Scheme 1 ), L5@LysSYL shows promise as a wound dressing for the management of wound infections. Schematic diagram representing the development of pH‐sensitive self‐assembling endolysin LysSYL‐loaded peptide L5@LysSYL hydrogels for the treatment of wound infections. A full‐thickness skin wound model was generated and infected with methicillin‐resistant S. aureus (MRSA). L5@LysSYL hydrogels effectively eliminated MRSA through bacterial membrane disruption, cross wall disturbing, and cell separation inhibition. Moreover, L5@LysSYL promoted wound healing by decreasing cytokine levels and increasing the key factors for vessel formation, working as a promising pH‐sensitive wound dressing for the management of wound infections. Results and Discussion Design, Synthesis, and Screening of pH‐Switchable Self‐Assembling Peptides Peptides of interest are designed in consideration of purpose and associated costs. However, peptide design and synthesis necessitate the appropriate residue properties and minimal functional motifs.[ 24 , 25 ] The diphenylalanine‐based simple peptides often exhibit self‐assembling capability and have received great attention.[ 24 , 26 ] In addition, amphipathic peptides, such as clavanin A possessing a pH‐sensitive activity, usually contain abundant amounts of histidine (H) and phenylalanine (F) residues.[ 27 ] Lysine (K) and arginine (R) residues provide a positive charge, glutamic acid (E) contributes a negative charge, and leucine (L) presents hydrophobicity in peptide sequences.[ 28 , 29 ] Furthermore, the carboxy‐terminal tripeptide (lysine–proline–valine, KPV) of α‐melanocyte‐stimulating hormone is a good motif exhibiting antimicrobial activity or anti‐inflammatory action.[ 30 ] In this study, three groups of peptides were designed based on the abovementioned information. Peptides L1–L3 contained various numbers of F and H residues arranged alternatively between N‐terminal LK and C‐terminal E, which enable their self‐assembling and render them with pH‐sensitive capabilities (Figure S1, Supporting Information). The N‐terminal LK was replaced with a KPV motif to obtain additional antimicrobial activities (peptides L4–L6), and the N‐terminal K of L1–L3 was replaced with the alternative basic residue R to acquire peptides L7–L9. Peptide Calculator and ProtParam were used to calculate the key physicochemical parameters of the designed peptides, and the results are shown in Table 1 . Table 1Amino acid sequences and physicochemical properties of peptides.PeptideSequenceTMWMMWPINet chargeGRAVYAliphatic indexGel formationL1Ac‐LKFHFE‐NH2 861.01860.987.90.1−0.265.0NoL2Ac‐LKFHFHFE‐NH2 1145.331145.307.90.2−0.548.8YesL3Ac‐LKFHFHFHFE‐NH2 1429.651429.657.90.3−0.739.0YesL4Ac‐KPVFFHHE‐NH2 1081.241081.247.90.2−0.136.3NoL5Ac‐KPVFQFLFHE‐NH2 1332.571332.577.90.1−0.568.0YesL6Ac‐KPVFHFFHHFE‐NH2 1512.741512.717.90.3−0.626.4NoL7Ac‐LRFHFE‐NH2 889.02889.029.30.1−0.265.0YesL8Ac‐LRFHFHFE‐NH2 1173.341173.349.30.2−0.548.8YesL9Ac‐LRFHFHFHFE‐NH2 1457.661457.669.30.3−0.739.0Yes TMW, theoretical molecular weight; MMW, measured molecular weight; pI, isoelectric point; GRAVY, Grand average of hydropathicity Amino acid sequences and physicochemical properties of peptides. TMW, theoretical molecular weight; MMW, measured molecular weight; pI, isoelectric point; GRAVY, Grand average of hydropathicity N‐Terminal acetylation and C‐terminal amination were performed for synthesis and modification of the designed peptides (L1–L9) to improve biological stability.[ 31 ] High‐performance liquid chromatography (HPLC) revealed that all the synthesized peptides were homogeneous (Figure S2, Supporting Information). Electron spray ionization–mass spectrometry (ESI–MS) showed that the measured molecular weights of the peptides were identical to the theoretical values (Figure S3, Supporting Information). The designed peptides had a predicted net charge close to zero in a solution having a pH between 7 and 8 and may exhibit a positive charge in acidic conditions (Figure S4a, Supporting Information). The GRAVY score prediction showed that all peptides were hydrophilic (GRAVY < 0).[ 32 ] L5 presented the highest aliphatic index (68.0), which suggests a high stability.[ 33 ] Moreover, gel formation property was determined using phosphate‐buffered saline (PBS) buffer (pH 7.4, 10 mM). The findings indicate that all peptides can form hydrogels in PBS at a concentration of 10 mg mL−1, except for L1, L4, and L6 (Figure S4b, Supporting Information). The formation of hydrogels is mainly influenced by the concentration of self‐assembling peptides.[ 34 ] Thus, the gel formation ability of L1, L4, and L6 was further evaluated with various peptide concentrations (1, 5, 10, 20, and 40 mg mL−1), and no gel formation was revealed (Figure S4c, Supporting Information). Next, the antimicrobial capability screening of the gelatinous peptides was performed. The findings indicate that peptides L2, L3, L5, L7, and L8 exhibited antimicrobial activity against S. aureus USA300 at pH 5.5 but not at pH 7.4 (Figure 1a), which confirms the pH‐switchable antimicrobial activity. However, L9 exhibited antimicrobial activity at pH 7.4 and 5.5. The AaeAP2a derivative peptides, which present bactericidal activity in neutral and acid environments, showed a similar result.[ 28 ] Accordingly, the numbers of S. aureus USA300 decreased by 2.8–4.1 log10 units after the treatment with L2, L3, L5, L7, and L8 (Figure 1b). Peptides L3 and L8 exhibited the highest antimicrobial potential against S. aureus USA300, and this finding may be attributed to the R or multiple H residues. Screening of peptides based on antimicrobial activity and biocompatibility. a) Agar plate assay for the antimicrobial activity of self‐assembling peptide hydrogels against S. aures UAS300. b) Bacterial colony counting assay. Data are presented as mean ± SD, n = 3. The statistical analysis was measured by unpaired Student's t‐test. P < 0.01, and ***P < 0.001. c,d) The viability of HaCaT cells after incubation with the extraction of peptide hydrogels (7.5 mm, pH 7.4) for (c) 24 h and (d) 48 h. The cell medium (M) served as a control, and its cell viability was adjusted to 100%. The relative HaCaT cell viabilities after treatment with diverse peptides were indicated. Data are presented as mean ± SD, n = 6. The statistical analysis was measured by one‐way ANOVA. **P < 0.01, ***P < 0.001, and ns indicates no significance. e) The hemolysis rate of peptide hydrogels against mouse red blood cells. f) Photographs of the hemolytic experiment. PBS served as a negative control and Triton X‐100 was used as a positive control. Cytocompatibility hinders the clinical application of peptide hydrogels.[ 35 ] Thus, we determined the cytotoxicity and hemolytic activity of the hydrogels derived from peptides designed via the Cell Counting Kit‐8 (CCK‐8) assay. The HaCaT cells treated with equimolar concentrations (7.5 mM, pH 7.4) of L2, L3, L5, L7, or L8 hydrogel extracts attained a relative proliferation rate of over 100% after 24 h exposure (Figure 1c), and only L5 remarkably promoted cell proliferation after 48 h treatment (Figure 1d). With the hydrogel extracts of pH 5.5, L5 revealed the lowest cell‐proliferation inhibitory activity among all tested peptides (Figure S5a,b, Supporting Information). These data indicate a good biocompatibility of L5 peptide hydrogels. Notably, the treatment with L5 at pH 7.4 resulted in the highest HaCaT cell proliferation rate of 170.0% for 24 h or 118.6% for 48 h relative to the control (100%, P < 0.001 or P < 0.01). By contrast, L9 treatment considerably decreased the cell proliferation rate at 48 h (P < 0.001). In addition, the self‐assembled peptide hydrogels exhibited an increased hemolytic activity in a dose‐dependent manner (Figure 1e,f). Importantly, the L5 hydrogels exhibited the lowest hemolytic activity toward mouse red blood cells, which resulted in a hemolysis rate of 0.20% at a concentration of 2500 µm. Therefore, based on its activity and biocompatibility, the L5 peptide was considered the leading candidate for further studies. Functional and Structural Characterization of L5 Hydrogels In the fields of tissue engineering and wound healing, injectable hydr+ogels have received considerable attention due to their capability to retain moisture, absorb wound exudate, permeate oxygen, and adapt to irregular wound shapes.[ 36 ] Certain peptides can self‐organize into hydrogels via π–π stacking and electrostatic and hydrogen‐bond interactions.[ 24 ] The designed K and E residues may provide a neutral charge for the hydrogel formation of peptide L5 at pH 7.4. However, the R‐side chain and imidazole group of H residues are protonated and show a positive charge at pH 5.5, which may result in the collapse of the self‐assembled supramolecular hydrogel (Figure 2a). Therefore, the biocompatibility of amphipathic L5 may be attributed to its intermolecular electrostatic interaction, hydrophobic stacking, and hydrogen bonding under neutral conditions (Figure 2b). The L5 peptide of various concentrations was prepared in a PBS buffer of diverse pH to observe gel formation (Figure S5c, Supporting Information). According to the results, L5 hydrogels (10 mg mL−1) were freely controlled and injected into the disc through a needle with an inner diameter of 0.4 mm, and the word “GEL” was successfully formed, which indicates the good syringeability of L5 hydrogels (Figure 2c). Moreover, a vial inversion method was performed to evaluate the pH‐responsive gel‐forming property of L5. L5 formed a solid gel at pH 7.4 after being left to stand for 30 min at room temperature, and an unstable gel emerged under acid conditions (pH 5.5) (Figure 2d). Circular dichroism (CD) analysis of L5 further confirmed changes in its secondary structures under various pH environments. As shown in Figure 2e, the CD spectrum of L5 at pH 7.4 had positive and negative peaks at 195 and 208 nm, which corresponded to β‐sheet and α‐helix conformations, respectively. However, the CD spectrum of L5 changed dramatically at pH 5.5 and presented a negative peak at 200 nm, which suggests the random coil conformation of L5 under pH 5.5. These findings were similar to those of a previous study, where the conformation of a marine organism Styela clava‐produced peptide clavanin A and its derivatives (AAP1 and AAP2) can transition from the less effective α‐helical form at neutral pH to more active random coil conformation at low pH.[ 34 ] The self‐assembling mechanism and characterization of L5‐based hydrogels. a) Chemical structure and charge state of peptide L5 under neutral and acidic conditions. b) Proposed molecular interactions of L5 to organize supramolecular peptide hydrogels at neutral pH. c) Injectability of L5 through a 26‐gauge needle. d) Photographs showed the phase transformation of L5 from pH 7.4 to 5.5 via a vial inversion method. e) CD spectra of L5 at pH 7.4 and 5.5. f–i) PI‐positive cells were detected via flow cytometry for f) S. aureus USA300 and h) P. aeruginosa PAO1 after treatment with L5 at pH 7.4 and 5.5; the percentage of dead bacteria of g) S. aureus USA300 and i) P. aeruginosa PAO1. Data are presented as mean ± SD, n = 6. The statistical analysis was measured by unpaired Student's t‐test. ***P < 0.001. Evaluation of the antimicrobial effect revealed the pH‐switchable antimicrobial capability of L5, which was attained through an enhanced bactericidal activity at pH less than 6 (Figure S6a,b, Supporting Information). Moreover, the ionic strength of PBS (pH 5.5) notably affected L5 antimicrobial activity, which was remarkably inhibited by 50 mM but not 10 mM PBS at pH 5.5 (Figure S6c, Supporting Information). Effects of buffer ionic strength on the release and activity of antimicrobial peptide hydrogels have been reported,[ 37 , 38 , 39 ] and high ionic strength may shield the charges on the surface of peptides, which causes reduced antimicrobial activity.[ 40 ] Subsequently, flow cytometric analysis, confocal laser scanning microscopy (CLSM), and scanning electron microscopy (SEM) were performed to further confirm the pH‐switchable antimicrobial activity of L5 against Gram‐positive S. aureus and Gram‐negative Pseudomonas aeruginosa (P. aeruginosa). Figure 2f–i indicates that after the treatment with L5 (pH 5.5) for 4 h, the percentages of PI‐permeable S. aureus USA300 and P. aeruginosa PAO1 cells reached 30.2% and 11.3%, respectively, which were significantly higher than those of L5‐treated cells at pH 7.4 (0.32% and 0.12%, respectively, P < 0.001). This finding indicates that L5 can disrupt cell membranes under acidic conditions. Moreover, live/dead bacterial staining assay unveiled the red staining of S. aureus and P. aeruginosa cells incubated with L5 hydrogels at pH 5.5, which represents dead bacteria. Meanwhile, a minimal amount of red‐colored bacteria was observed after the treatment with L5 hydrogels at pH 7.4 (Figure 3a). SEM revealed the intact cell morphology and smooth surface of S. aureus and P. aeruginosa cells treated with L5 hydrogels at pH 7.4. However, the bacterial cells presented evident cell membrane deformation and surface collapse after their incubation with L5 hydrogels at pH 5.5 (Figure 3b). In addition, L5 hydrogels eliminated MRSA strains USA300 and XN108 under acidic conditions in a dose‐ and time‐dependent manner (Figure 3c). Furthermore, the agar plate assays revealed the broad‐spectrum antimicrobial activity of L5 hydrogels against S. aureus, P. aeruginosa, Acinetobacter baumannii (A. baumannii), and Escherichia coli (E. coli; Figure 3d). Overall, L5 hydrogel showed a broad‐spectrum antibacterial capability under acidic conditions, which implies its potential as an antibacterial agent for wound dressing. The broad‐spectrum antimicrobial activity of peptide L5‐based hydrogels. a) Fluorescent images of live/dead bacterial staining after treatment with L5 (pH 7.4 or 5.5) for 4 h. Scale bar: 20 µm. b) SEM images of S. aureus USA300 and P. aeruginosa PAO1 cells treated with L5 under pH 7.4 and 5.5. c) Agar plate assay for the time and concentration‐dependent killing of S. aureus with L5 peptide under pH 5.5. d) The antimicrobial activity of L5 against S. aureus, A. baumannii, P. aeruginosa, and E. coli under pH 7.4 and 5.5. In addition, cryo‐electron microscopy (cryo‐EM) revealed that the L5‐based hydrogels at pH 7.4 exhibited a uniform and entangled 3D porous morphology with a mean pore diameter of 5.6 µm, which provided a suitable supramolecular network for drug delivery. However, the 3D supramolecular network was disassembled and disrupted under acid conditions probably due to the protonation of K and H residues in the L5 sequence (Figure 4a). Transmission electron microscopy (TEM, Figure 4b) and atomic force microscopy (AFM, Figure 4c) also unveiled the long and curved nanofiber networks of L5‐based hydrogels at pH 7.4, whereas the nanofibers became incomplete and fractured under acidic conditions. In addition, the fiber diameter of L5 at pH 7.4 (8.9 ± 0.8 nm, Figure 4d) was considerably larger than that at pH 5.5 (6.1 ± 0.4 nm, Figure 4e). Overall, these results demonstrate the pH‐sensitive antimicrobial activity of L5‐based hydrogels. The entangled 3D porous morphology of L5‐based hydrogels at pH 7.4 implies its potential for drug delivery. Structural observation of peptide L5‐based hydrogels. a) Representative cryo‐EM image of L5 at pH 7.4 and 5.5. b) Representative TEM image of L5 at pH 7.4 and 5.5. c) Representative AFM image of L5 at pH 7.4 and 5.5. d,e) The diameter of L5 nanofibers at d) pH7.4 and e) pH 5.5. Preparation and Characterization of Endolysin‐Loaded L5@LysSYL Hydrogels The applications face limitations resulting from the stability of endolysins under diverse conditions.[ 41 ] LysSYL serves as a broad‐spectrum endolysin against staphylococcal bacteria.[ 3 ] To obtain a stable LysSYL agent, we applied peptide L5 hydrogel to carry LysSYL. The PBS‐diluted purified endolysin LysSYL (pH 7.4) was used to dissolve peptide L5 to a final concentration of 10 mg mL−1, and the resulting solution was kept at room temperature for hydrogel formation. Then, HPLC was performed to detect the encapsulation efficiency of LysSYL in the L5@LysSYL hydrogels, with a value of 85.7% achieved when 1 mg mL−1 endolysin LysSYL was used. A thermal stability test revealed a 21.7% higher bactericidal activity of LysSYL‐encapsulated L5@LysSYL hydrogels than free LysSYL after incubation at 80 °C for 10 min (Figure 5a). In addition, endolysin LysSYL attained a significantly increased thermal stability after its encapsulation with L5 hydrogels (95.2% vs 73.5%, P < 0.01). Characterization of endolysin LysSYL‐loaded pH‐switchable L5@LysSYL hydrogels. a) Thermal stability of LysSYL after encapsulation in L5 hydrogels. The antimicrobial activity of LysSYL against S. aureus USA300 at 4 °C was adjusted to 100%. The relative bactericidal activity of LysSYL and L5@LysSYL pretreated at 80 °C for 10 min was conducted and indicated. Data are presented as mean ± SD, n = 3. The statistical analysis was measured by one‐way ANOVA. **P < 0.01, ***P < 0.001, and ns represents no statistical significance. b) Oscillatory rheology measurement of L5 and L5@LysSYL hydrogels. c) FTIR spectra of LysSYL, L5@LysSYL, and peptide L5. d) Representative cryo‐EM image of L5@LysSYL at pH 7.4. e) Representative TEM image of L5@LysSYL at pH 7.4. f) Representative AFM image of L5@LysSYL at pH 7.4. g) The diameter of L5@LysSYL nanofibers at pH 7.4. h) Cumulative release of LysSYL from L5@LysSYL hydrogels at pH 7.4 and 5.5. Data are presented as mean ± SD, n = 6. Next, the rheological property was investigated for assessing the viscoelasticity of the prepared hydrogels, which is mainly indicated by the storage modulus (G′) and loss modulus (G″).[ 42 ] The results showed that the endolysin LysSYL‐loaded L5@LysSYL hydrogels exhibited a larger G′ than G″ and a similar result was observed for L5 hydrogels (Figure 5b). This outcome confirmed hydrogel formation.[ 43 , 44 ] Notably, L5@LysSYL presented greater G' values than L5, which indicates the improved mechanical property of the L5@LysSYL hydrogels, and the increased cross‐linking in L5 hydrogels after the addition of LysSYL may be responsible for the phenomenon.[ 45 ] Moreover, analysis of the Fourier transform infrared (FTIR) spectra of L5@LysSYL, LysSYL, and L5 was performed, and the results revealed that all samples tested exhibited absorption peaks at ≈3400 and 2900 cm−1 (Figure 5c), which correspond to O─H, N─H, and C─H stretching vibration. Observation of L5@LysSYL hydrogels revealed the typical FTIR peaks of LysSYL (1740 cm−1) and peptide L5 (1637 cm−1), which indicates the successful encapsulation of endolysin LysSYL in L5@LysSYL hydrogels. L5@LysSYL (1637 cm−1) and L5 (1636 cm−1) hydrogels showed identical peak shapes, which suggests that LysSYL loading caused no effect on the L5 hydrogel structure. Furthermore, cryo‐EM revealed a significantly larger mean pore diameter of L5@LysSYL (22.5 µm, Figure 5d) than L5 hydrogels (5.6 µm, P < 0.01, Figure 4a). TEM revealed that L5@LysSYL possessed similar nanofiber networks to those of L5 at pH 7.4 (Figures 4, 5), and AFM unveiled the larger fiber diameter of L5@LysSYL (13.2 ± 0.5 nm) than L5 at pH 7.4 (8.9 ± 0.8 nm) and 5.5 (6.1 ± 0.4 nm) (Figures 4, 5). Overall, the obtained data demonstrate the remarkable influence of pH on the conformation of endolysin‐loaded L5@LysSYL hydrogels, which indicates their pH‐sensitive physicochemical properties. The degradation assays for L5 and L5@LysSYL hydrogels were performed as previously described,[ 42 ] and the results showed that the load of endolysin LysSYL did not affect the degradation of L5 hydrogels (Figure S7, Supporting Information). HPLC was further used to evaluate the in vitro release behavior of L5@LysSYL hydrogels. Figure 5h shows the rapid release of endolysin LysSYL from L5@LysSYL at the beginning of 12 h and its sustained release over 120 h at pH 5.5. At neutral and acidic pH, LysSYL‐loaded hydrogels achieved cumulative release percentages of 17.9% and 83.6% at 72 h, respectively, which indicates a 4.7‐fold higher sensitivity to release LysSYL in the pathologically infected wound environment (pH 5.5). These findings suggest the remarkable effect of pH on the release profile of LysSYL from L5@LysSYL hydrogels and indicate a fast release rate of LysSYL under low pH. The reason may be ascribed to the changes in the nanofiber morphology of L5@LysSYL hydrogels. Inactivation of S. aureus by L5@LysSYL Hydrogels Although peptide L5 exhibited bactericidal activity at pH 5.5 (Figure 1a,b), endolysin LysSYL is a peptidoglycan hydrolase targeting staphylococcal bacteria.[ 3 ] We speculated the possible increase in the antimicrobial activity of L5@LysSYL against S. aureus after the encapsulation of endolysin LysSYL with L5 hydrogels. To test this speculation, we used S. aureus strain USA300 to evaluate the L5@LysSYL activity. The results showed that the treatment with L5@LysSYL for 1, 8, 16, or 24 h remarkably reduced the numbers of S. aureus USA300 compared with the L5 treatment alone (Figure 6a, P < 0.001); however, the treatment with peptide L2‐encapsulated endolysin L2@LysSYL hydrogels for 1 h revealed a comparable bacterial number relative to the L2 control group (Figure S8a, Supporting Information). In addition, optical density (OD) measurement was conducted to evaluate the inhibition of S. aureus strain USA300 after exposure to L5@LysSYL, free LysSYL, and L5. Similar growth curves were obtained for USA300 without hydrogel treatment at pH 7.4 and 5.5, whereas bacterial growth was gradually inhibited by L5@LysSYL at pH 5.5, with the best inhibitory effect exhibited at 24 h post treatment (Figure 6b). These findings indicate the sustained‐release effect of L5@LysSYL hydrogels. Peptide L5 slightly inhibited the growth of S. aureus USA300 at pH 5.5. Notably, exposure to LysSYL at pH 7.4 dramatically inhibited the growth of USA300 within 18 h. Afterward, bacterial growth showed a considerable increase (Figure 6b). By contrast, LysSYL exhibited a limited antimicrobial influence at pH 5.5, which suggests a low activity of endolysin LysSYL under acidic conditions. Similar findings were observed in the case of S. aureus XN108 (Figure S8b, Supporting Information). Overall, the results indicate that the encapsulation of endolysin LysSYL with L5 peptide hydrogels enabled a sustained‐release effect and a strong antimicrobial activity against S. aureus isolates. The antimicrobial activity and RNA‐seq analysis of L5@LysSYL hydrogels against S. aureus. a) Colony counting assay for the bactericidal activity of L5@LysSYL against S. aureus USA300. PBS served as a negative control and L5 and LysSYL were used as positive controls. Data are presented as mean ± SD, n = 3. The statistical analysis was measured by one‐way ANOVA, ***P < 0.001, and ns represents no significance. b) Growth curve of S. aureus USA300 cultured with L5, L5@LysSYL, LysSYL under different pH conditions. The growth of S. aureus strains without hydrogel treatment served as a control. Data are presented as mean ± SD, n = 3. c) Volcano plot analyses of total differential expression genes (DEGs) of S. aureus USA300 after treatment with L5@LysSYL for 1 h. d) GO enrichment analysis of upregulated DEGs (Top 10). e) GO enrichment analysis of downregulated DEGs (Top 10). f) Fragments per kilobase million (FPKM) of mhG2, mnhF2, SAUSA300_RS06675, and phnE genes associated with transmembrane transport. Data are presented as mean ± SD, n = 3. The statistical analysis was measured by unpaired Student's t‐test, **P < 0.01. g) KEGG enrichment analysis of the DEGs. Red bars show the number of upregulated DEGs involved in certain metabolic pathways, while the blue bars indicate that of downregulated DEGs. Antimicrobial peptides, including self‐assembling peptides, exhibit a complex mode of action. Several mechanisms underlying antimicrobial peptide activity, such as bacterial membrane disruption, DNA damage, RNA interference, and protein inactivation, have been proposed.[ 46 , 47 ] Notably, antimicrobial peptides must interact with membranes as one of their direct antibacterial action mechanisms, leading to membrane perturbation and membrane‐associated protein disruption.[ 39 ] RNA sequencing (RNA‐Seq) was performed to explore the effect of L5@LysSYL on S. aureus cells. A total of 429 differentially expressed genes (DEGs) with 187 and 242 upregulated and downregulated genes, respectively, (P < 0.05 and |fold change| > 1.5) in S. aureus USA300 were identified after treatment with L5@LysSYL (Figure 6c). Gene Ontology enrichment analysis showed the significant inhibition of the genes involved in membrane, ABC transporters, transmembrane transport, and phosphoenolpyruvate‐dependent sugar phosphotransferase system (PTS) in S. aureus posttreatment with L5@LysSYL hydrogels (Figure 6d,e). This result implies the capability of L5@LysSYL to directly target the S. aureus cell membrane and impair membrane function. This finding is consistent with the finding that L5 hydrogels can induce S. aureus cell death via membrane disruption (Figures 2, 3). The membrane term involved in interfering with the expression of membrane protein and inner membrane protein genes, such as genes encoding tetracycline efflux major facilitator superfamily (MFS) transporter (tet(38) and tet(K)), multidrug efflux MFS transporter (mdeA), glucose‐specific PTS transporter subunit (ptsG), branched‐chain amino acid transport system (brnQ), YSIRK domain‐containing triacylglycerol lipase (lip2) and heme uptake protein (isd); the expression of genes encoding cell‐wall‐associated surface proteins related to LPXTG (X represents any residue) cell wall anchor motif (sasA and sdrC) and CPBP (CAAX Protease and Bacteriocin‐Processing) family intramembrane glutamic endopeptidase (spdA) were also downregulated by L5@LysSYL (Figure 6e). Cell wall‐associated proteins can covalently anchor to the bacterial cell wall, and S. aureus requires these surface proteins to cause disease.[ 48 ] Such proteins usually have a conserved LPXTG motif essential for sortase recognition and cleavage, and the cleaved proteins covalently link to the nascent pentaglycine crossbridge in the peptidoglycan via amide bond formation.[ 48 , 49 ] S. aureus strains have at least 24 cell wall‐associated proteins.[ 50 ] The surface protein A (SpA) is abundantly located at cell division sites, where the cross walls are formed, and three genes designated as spdA, spdB, and spdC are required for the deposition of SpA.[ 49 ] It is reported that the SpA proteins of S. aureus can modify the cell surface to prevent phage infection or protect themselves from antimicrobial killing.[ 49 ] RNA‐seq revealed that L5@LysSYL may perturb the cross‐wall formation and arrest bacterial separation through the inhibition of genes encoding cross wall factors, and LysSYL can target chemical bonds, including β‐1,4 glycosidic bond, amide bond, and peptide bond, to inhibit the biosynthetic process of peptidoglycan and disrupt the integrity of the cell wall,[ 3 , 15 ] resulting in a decreased expression levels of the cell wall‐associated proteins. Moreover, the DEGs related to transmembrane transport, organic substance transport, carbohydrate transport, ion transmembrane transporter, cation transmembrane transporter, carbohydrate and transmembrane transporter were observed. The genes (mnhG2, mnhF2, SAUSA300_RS06675, and phne) encoding transmembrane transport‐associated proteins were significantly downregulated (P < 0.01 or 0.001, Figure 6f). However, GO enrichment analysis showed that the genes mostly associated with intracellular organelle, cytoplasmic part, ribosome, and other cellular components were significantly upregulated (Figure 6d), which indicates that the bacteria may initiate the repair process to minimize the damage of L5@LysSYL. In addition, Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis showed that the pathways associated with PTS, nitrogen metabolism, terpenoid backbone biosynthesis, quorum sensing, alanine, aspartate, and glutamate metabolism, and C5‐branched dibasic acid metabolism were clearly impacted (Figure 6g). These results indicated that L5@LysSYL hydrogel treatment can influence different biosynthetic processes and metabolic processes undergo widespread changes in S. aureus cells. Overall, these data suggest that L5@LysSYL hydrogels can disrupt bacterial cell membranes, inhibit cross‐wall formation, and delay cell separation. However, the underlying mechanism may involve multiple synergistic modes. Future studies should focus on the further exploration of the antimicrobial mechanism of L5@LysSYL hydrogels in more detail. Promotion of Wound Healing by L5@LysSYL Hydrogels S. aureus is the most common pathogenic cause of SSTIs.[ 51 ] The wound healing efficacy of L5‐based hydrogel dressing was evaluated by establishing a full‐thickness skin‐wound model infected with S. aureus USA300 (108 CFU). The wounds were observed on days 0, 3, 7, and 14, and wound tissues were collected on days 7 and 14 (Figure 7a). Macroscopically, the L5@LysSYL hydrogel‐treated mice presented excellent wound healing on days 7 and 14 compared with the other groups (Figure 7b). The traces of wound healing within 14 days of treatment were recorded using various colors (Figure 7c), and the quantitative findings unveiled the highest closure rates of the mouse wounds after the treatment with L5@LysSYL hydrogels (Figure 7d). On day 7, the unhealed wound areas of 92.1%, 75.1%, 69.9%, and 77.2% were observed in mice treated with PBS, LysSYL, L5, and commercial mupirocin (Mup) dressing, respectively, whereas 38.4% of the wound area remained after the treatment with L5@LysSYL hydrogels. On day 14, the uncovered wound area of L5@LysSYL hydrogel‐treated mice accounted for 4.9%, which was significantly less than those of PBS (35.0%, P < 0.001), LysSYL (27.2%, P < 0.01), L5 (24.3.0%, P < 0.001), and Mup (21.1%, P < 0.05). Moreover, the bacterial loads in wound skins were considerably reduced after the treatment with L5@LysSYL hydrogels compared with that of the PBS‐treat group on day 7 (P < 0.001, Figure 7e). However, the bacterial counts of the other treatment groups were comparable to those of the PBS control. After 14 days of L5@LysSYL treatment, S. aureus USA300 counts showed a decrease by 6 log10 units, which were superior to those of the LysSYL‐treated (2.3 log10 units) and Mup‐cured (1.5 log10 units) groups. These results demonstrate that LysSYL‐coordinated L5 hydrogels possess an enhanced wound healing capability than the commercial dressing Mup.[ 52 ] L5@LysSYL hydrogels promoted S. aureus USA300‐infected wound healing. a) Schematic diagram showing the animal experimental procedure. b) Representative photographs of the infected full‐thickness wounds after treatment with LysSYL, L5, L5@LysSYL, and commercial mupirocin (Mup) dressing (positive control) on days 0, 3, 7, and 14 (n = 5). PBS served as a negative control. Scale bar: 5 mm. c) Schematic diagrams of wound closure progression traced over 14 days. Scale bar: 10 mm. d) Quantitative analysis of wound closure rate (% of original wound). Data are presented as mean ± SD, n = 5. e) Bacterial count from the wound tissues on days 7 and 14. Data are presented as mean ± SD, n = 3. f–i) Cytokine levels of f) TNF‐α, g) IL‐1β, h) MCP‐1, and i) IL‐10 of wound tissues on day 7 were detected by ELISA. Data in (d–i) are presented as mean ± SD, n = 3. The statistical analysis was measured by one‐way ANOVA. *P < 0.05, **P < 0.01, ***P < 0.001, and ns indicates no statistical significance. The difficulty arises from the healing of bacterially infected wounds due to excess cytokine production; in addition, fibroblast functions, such as proliferation and migration, are probably impaired by inflammation.[ 9 ] An anti‐inflammatory activity may exert due to the KPV tripeptide designed at the N‐terminal of peptide L5.[ 30 ] Enzyme‐linked immunosorbent assay (ELISA) was conducted to detect the cytokines and chemokines of skin lesions of mice 7 days after treatment. Figure 7f–i displays that L5@LysSYL hydrogels decreased the levels of pro‐inflammatory cytokines and chemokine but increased that of the anti‐inflammatory cytokine interleukin‐10 (IL‐10) at wound sites compared with the PBS control. The alteration degrees of cytokine and chemokine in the L5@LysSYL‐treated mice were superior to those of LysSYL and L5 treatment alone, which indicates a switch from inflammation to a proliferative process for wound healing. Wound tissues were collected for hematoxylin and eosin (H&E) staining and analysis. Compared with normal skin tissues, wound tissues obtained from the PBS‐treated S. aureus‐infected mice showed the formation of thin and loose immature granulations, infiltration of predominant inflammatory cells, and sparse deposition of fibroblasts and blood vessels on day 7. Moderately thick inflammatory granulation tissue dominated with inflammatory cells formed, and numerous newly formed blood vessels emerged on day14 (Figure 8a). By contrast, the L5@LysSYL hydrogel‐treated group exhibited a normal skin structure with an orderly arrangement of subcutaneous fibrous tissue and the disappearance of inflammation on day14, which is consistent with the macroscopic observation. Wound tissue remodeling requires the proper deposition of collagen and fibrosis.[ 53 ] Thus, Masson staining was conducted to observe newly formed collagen in various treatment groups (Figure 8a). On day 14, the L5@LysSYL‐treatment group showed the highest collagen deposition ratio (38.4%), which is comparable to that of the normal group (41.8%, Figure 8b). This finding demonstrates that L5@LysSYL accelerated total collagen formation and deposition. L5@LysSYL hydrogels accelerated wound healing by upregulating genes involved in tissue regeneration. a) H&E and Masson trichrome staining of infected wound tissues in various treatment groups on days 7 and 14. The black arrows show the infiltration of predominant inflammatory cells, yellow arrows indicate the deposition of fibroblasts, red arrows point the new blood vessels, and orange arrows indicate the collagen deposition for H&E images. In the Masson images, white arrows indicate the collagen deposition. b) The values of collagen deposition percentage were calculated from the corresponding images. The relative expressions of c) vegf, d) egf, and e) fgf of the wound tissues were determined by RT‐qPCR. Data in (b–e) are presented as mean ± SD, n = 3. The statistical analysis was measured by one‐way ANOVA. *P < 0.05, **P < 0.01, ***P < 0.001, and ns indicates no statistical significance. Next, systematic evaluation of the angiogenesis and epithelialization of the wounds was performed via quantitative polymerase chain reaction (qPCR) and immunohistochemical staining. The factors for angiogenesis and epithelialization coordinately promote cell proliferation, vascular formation, and collagen deposition, which support wound healing and skin repair.[ 54 ] Figure 8c–e presents the remarkably increased expressions of vegf, egf, and fgf after their treatment with L5@LysSYL hydrogels compared with those under PBS treatment on day 7. CD31 is considered an endothelial cell marker expressed obviously in the subepidermal connective tissue at skin wounds.[ 45 ] Notably, more CD31 was observed after L5@LysSYL hydrogel treatment (mean OD of 0.34) relative to the PBS‐treated group (mean OD of 0.17, P < 0.05), which indicates that more vessels were formed (Figure 9a,b). Particularly, the L5@LysSYL hydrogel‐treatment mice showed the highest vascular endothelial growth factor (VEGF) expression among all groups (Figure 9c,d). Overall, this information suggests that L5@LysSYL hydrogels can promote wound healing by eliminating bacteria, decreasing pro‐inflammatory cytokine and chemokine levels, increasing those of anti‐inflammatory cytokines, and upregulating the key factors driving vessel formation. Immunohistochemical staining analysis. a) Representative images of CD31 staining. Blue arrows represent CD31‐positive cells. b) The density of CD31‐positive dots in (a). c) Representative images of VEGF staining. Red arrows indicate VEGF‐positive cells. d) The density of VEGF‐positive dots in (c). Data in (b) and (d) are presented as mean ± SD, n = 3. The statistical analysis was measured by one‐way ANOVA. *P < 0.05, **P < 0.01, and ns indicates no statistical significance. Safety of L5@LysSYL Hydrogels to the Skins L5@LysSYL is a desirable candidate for wound healing dressing, and its potentially direct toxicity and other effects when in contact with skin tissues pose primary concerns for its clinical application.[ 55 ] Therefore, the toxicity of L5@LysSYL toward mouse skins was examined. The treatment with L5@LysSYL, LysSYL, and L5 hydrogels revealed no evident macroscopic signs on the skins (Figure S9a, Supporting Information). The treatments caused symptoms and signs comparable to those obtained with the PBS control. However, the skin tissues of 30% sodium dodecyl sulfate (SDS)‐treated mice exhibited epidermal peeling and erythema (Figure S9a, Supporting Information). Moreover, H&E staining revealed the following in the skin tissues of 30% SDS‐treated mice: excessive keratinization of the stratum corneum, thickening of the epidermal spinous layer, dilation of subepidermal capillaries, and infiltration of inflammatory cells (Figure S9b, Supporting Information). By contrast, the treatment with LysSYL, L5, and L5@LysSYL hydrogels did not reveal evident pathological features on the skins. Overall, these data suggest that L5@LysSYL hydrogel is safe for wound administration. Conclusion In conclusion, a series of self‐assembly peptides were designed based on residue properties and functional motifs, and peptide L5 was screened out for its pH‐switchable gel formation property, good biocompatibility, high antimicrobial activity, and low hemolytic action. The L5 hydrogel is capable of delivering endolysin LysSYL, and L5@LysSYL hydrogels were easily prepared. L5@LysSYL hydrogels improved the stability and bioavailability of LysSYL and presented a sustained‐release effect. L5@LysSYL exhibited excellent elimination activity against MRSA, and the mechanism underlying L5@LysSYL killing of staphylococcal cells might involve in membrane destruction and cross‐cell wall inhibition. The in vivo study revealed that L5@LysSYL hydrogels are safe and can effectively promote wound healing, suggesting a promising pH‐sensitive system for the treatment of S. aureus infections. Taken together, the integrated hydrogel system in our study opens a novel approach in the development of wound dressings for the management of wound infections. Experimental Section Bacterial Strains, Cell Line, and Culture S. aureus strain XN108 (MRSA) was isolated from a burn patient with skin wound infection and bacteremia.[ 56 ] MRSA strains USA300 (FPR3757) and N315 were provided by Dr. Min Li (Shanghai Jiao Tong University, China) and Prof. Fangyou Yu (Tongji University School of Medicine, China), respectively. A. baumannii ATCC 19606, P. aeruginosa PAO1, and E. coli O157 were purchased from China Center for Type Culture Collection. S. aureus strains were cultivated in brain heart infusion (BHI) medium (Oxoid) or BHI agar (BHIA). The Gram‐negative strains were grown in Luria Bertani (LB) medium (Oxoid). HaCaT keratinocytes were purchased from Zhong Qiao Xin Zhou Biotechnology Co., Ltd (Shanghai, China) and cultured with Dulbecco′s Modified Eagle′s Medium (DMEM) supplemented with 10% (v/v) fetal bovine serum (FBS) at 37 °C with 5% (v/v) CO2. Design, Synthesis, and Characterization of Peptides The self‐assembly pH‐sensitive peptides were designed according to the properties of amino acids and functional motifs.[ 30 , 34 ] The sequence and structure of the designed peptide are shown in Figure S1 (Supporting Information). All peptides were synthesized using the Fmoc solid‐phase peptide synthesis method by ChinaPeptides Co., Ltd. (Shanghai, China) and modified with acetylation and C‐terminal amination for stabilizing the peptide structure as described.[ 31 ] The crude product was purified by HPLC and the purity of the peptides was more than 98%. The designed peptides were identified by HPLC and ESI‐MS, and the correct peptides were subjected to screening. Preparation of Peptide Hydrogels The synthesized peptides were each dissolved in PBS buffer (pH 7.4) to a final concentration of 10 mg mL−1, sonicated for 5 min, and kept at room temperature for hydrogel formation. In the preparation of endolysin‐loaded peptide hydrogels, LysSYL stock was diluted in PBS (pH 7.4), and the peptide powder was then dissolved in the endolysin solution until a stable hydrogel had formed. Antimicrobial Activity of Peptide‐Based Hydrogels MRSA USA300 was cultured in BHI at 37 °C until the mid‐log phage. The culture was centrifuged at 6000 × g for 10 min and the bacterial cells were resuspended with 10 mm PBS of pH 7.4 or 5.5. Then, 200 µL of bacterial suspension (5 × 106 CFU mL−1) were applied onto 50 µL peptide (7.5 mm) hydrogels formed in a 1.5 mL centrifuge tube in advance and incubated at 37 °C for 8 h. After incubation, the solution was spread onto BHIA plates and cultured at 37 °C overnight. On the next day, the plates were photographed and S. aureus colonies were counted. Cytocompatibility of Peptide‐Based Hydrogels The biocompatibility of peptide hydrogels was performed by testing their effect on mammalian cells and erythrocytes as previously described.[ 57 ] The peptide hydrogels were extracted with DMEM medium (pH 7.4 or 5.5) containing 100 U mL−1 penicillin and 100 µg mL−1 streptomycin at 37 °C for 24 h and the extraction ratio was 0.1 g mL−1. Then the infiltration solutions were mixed with 10% (v/v) FBS and filtered through a 0.22‐µm filter (Millipore, USA). HaCaT cells were seeded into 96‐well plates (2 × 104 cells well−1) and incubated at 37 °C for 24 h, and the media were replaced with the infiltration medium, and cells were incubated for another 24 or 48 h. After incubation, the cell viability was evaluated using the CCK‐8 kit (ABclonal Technology, China), and the absorbance was measured at 450 nm. HaCaT cells cultured in a normal medium (OD control) served as a negative control, and the cell‐free culture medium was used as a blank control. The cell viability was calculated as follows: Cell viability (%) = (OD samples/OD control) × 100. Hemolysis of Peptide‐Based Hydrogels The hemolysis assays were performed using fresh mouse erythrocytes as described.[ 9 ] The mouse blood cells were collected, washed three times with PBS, and diluted to 8% (v/v) erythrocyte suspension. Peptide hydrogels and erythrocyte suspension were mixed in equal volume and incubated at 37 °C for 1 h. After incubation, the mixture was centrifuged, the supernatant (100 µL) was added into 96‐well plates and measured at 540 nm. PBS and 0.1% Triton X‐100 were used as blank control (OD 0) and positive control (OD 100), respectively. The percentage of hemolysis was calculated as follows: Hemolysis (%) = [(OD samples − OD 0)/(OD 100 − OD 0)] × 100. Circular Dichroism (CD) Spectroscopy CD spectroscopy was determined to test the effect of pH values on the secondary structure of L5. L5 hydrogel (50 µL) was mixed with 200 µL PBS (pH 7.4 or 5.5) and incubated at 37 °C for 2 h. After incubation, the PBS buffer was removed. Then the surface of hydrogels was washed twice with dH2O and diluted with ddH2O to create a solution with a concentration of 100 µg mL−1. CD spectra were recorded on a JASCO J‐1500 spectropolarimeter (Japan) over the wavelength range of 180–260 nm for three times continuously. The Chirascan spectrometer was used to calculate the percentages of secondary structure of L5 at various pH conditions. Rheology Properties of Hydrogels The rheological property of L5‐based hydrogels was assessed by a rotational rheometer (MCR92, Anton Paar, Austria) under an oscillation‐frequency sweep model. The sample of hydrogels was placed onto a parallel plate with a 0.5 mm plate clearance. Frequency sweeps were performed between 0.1 and 100 rad s−1, with a constant strain (1%) at room temperature. Fourier Transform Infrared (FTIR) Spectroscopy The hydrogel samples were freeze‐dried into powder. The powder of the sample and potassium bromide mixed in a mortar were fully ground and then compressed using a tablet press. The FTIR spectra of the samples were measured on a Nicolet iS20 (Thermo Fisher Scientific, USA) in the range of 4000–400 cm−1 with a resolution of 4 cm−1. Dynamic Light Scattering (DLS) Analysis The peptide hydrogels were treated with PBS of different pHs as mentioned in CD detection. The sample solutions (25 µg mL−1) in ddH2O were added into the cuvette and performed on a Malvern Zetasizer Nano ZS90, with a running time of 60 s. Protein was chosen as the solute for the refractive index, and the temperature was set to 25 °C. The cuvettes were washed three times with ddH2O before the next sample input. The particle size of the hydrogel fibers was determined in triplicate. Transmission Electron Microscopy (TEM) L5‐based hydrogels were treated with PBS buffer (pH 7.4 or 5.5) and incubated at 37 °C for 2 h. The hydrogels were stained with 1% phosphotungstic acid at room temperature and visualized on a JEM‐1400‐FLASH (JEOL, Japan). Cryo‐Electron Microscopy (Cryo‐EM) The peptide hydrogels were prepared as mentioned in the CD measurement, snap‐frozen in liquid nitrogen for 30 s, and transferred to a Cryo‐EM holder under cryogenic conditions. Then the samples were sublimated at −90 °C for 10 min and gold‐plated and observed and performed on a Zeiss Sigma 300 for Cryo‐EM (Germany). The pore diameters were analyzed by Image J software. Atomic Force Microscopy (AFM) The microstructure of L5‐based hydrogels was assessed using a Bruker Dimension Icon spectrophotometer (Germany). About 10 µL hydrogels were evenly spread onto a glass slide, allowed to adsorb to the substrate surface, air‐dried, and examined for AFM imaging. The AFM images and spectroscopy data were analyzed by NanoScope Analysis 3.00 software. Flow Cytometer Analysis The S. aureus USA300 and P. aeruginosa PAO1 cells grown in a mid‐log phase were collected, washed with PBS, and diluted to 5 × 106 CFU mL−1 with PBS (pH 7.4 or 5.5, 10 mM). The bacterial suspensions were incubated with hydrogels at 37 °C for 4 h. Then the cells were stained with propidium iodide (PI) and detected using a FACS Calibur Flow Cytometer (BD, Franklin Lakes, NJ, USA). PBS was used as a negative control. Live/Dead Bacterial Staining Assay The live or dead bacteria was observed by CLSM. Bacteria with intact cell membranes were stained green, while those displaying damaged membranes were stained red. The bacteria were prepared as mentioned above, and the bacterial suspension was dyed with a LIVE/DEAD BacLight staining kit (Thermo Fisher Scientific) in the dark for 15 min and observed by a Zeiss LSM880 confocal microscope (Carl Zeiss, Germany). Scan Electron Microscopy (SEM) The morphological changes of bacteria after treatment with L5 hydrogels were observed by SEM. The bacterial cells were washed with PBS, fixed, dehydrated, dried, sputtered, and observed by a JSM‐IT700HR SEM (JEOL, Japan) Antimicrobial Activity of L5 Hydrogels The antimicrobial activity of L5 hydrogels against MRSA strains USA300 and XN108 was evaluated using agar assay. The S. aureus cells at the mid‐log phase were diluted to 5 × 106 CFU mL−1 with PBS (pH 5.5, 10 mM). Then 200 µL of bacterial suspension was incubated with different volumes of L5 hydrogels (10, 50, or 100 µL) at 37 °C for 2, 4, 6, 8, 10, or 12 h. PBS was used as a negative control. Moreover, the broad‐spectrum antimicrobial activity of L5 hydrogels against other bacteria including MRSA N315, A. baumannii ATCC 19606, P. aeruginosa PAO1, and E. coli O157 was determined. The bacterial cells at the mid‐log phase were diluted to 5 × 106 CFU mL−1 with PBS (pH 7.4 or 5.5, 10 mM). Then 50 µL of L5 hydrogels was mixed with 200 µL of bacterial suspension and incubated at 37 °C for 8 h. After incubation, 50 µL of bacterial suspension was spotted on the BHI agar plates. After culture at 37 °C for 24 h, the colonies were counted. Encapsulation Efficiency of Endolysin with L5 Hydrogels To detect the encapsulation efficiency of endolysin in L5@LysSYL, 10 mg of L5 was dissolved in endolysin solution (1 mg mL−1) and the hydrogel was centrifuged at 2000 rpm for 3 min to remove bubbles. Subsequently, the surface of L5@LysSYL was washed with 250 µL PBS (pH 7.4) for 3 times and all PBS solutions were collected in a 1.5 mL centrifuge tube. The concentration of endolysin in the rinse solution was detected by HPLC based on a standard curve. The encapsulation efficiency was calculated as follows: Encapsulation efficiency (%) = (M 0 − M 1)/M 0, where M 0 is the mass of endolysin input and M 1 is the mass of endolysin in rinse solution. Drug Release from L5@LysSYL Hydrogels The in vitro release of endolysin from L5@LysSYL hydrogels was determined under different pH as described.[ 58 ] Briefly, 1 mL PBS (pH 7.4 or 5.5) was placed onto the surface of 250 µL L5@LysSYL hydrogels, putting in a constant temperature shaker at 37 °C for 72 h. The total volume of PBS above the hydrogels was sampled and an equal volume of fresh PBS was added immediately at the indicated time points. The amount of released endolysin was measured by HPLC. The drug release curve was plotted by calculating the cumulative drug release percentage against time. In Vitro Degradation of Hydrogels In vitro, degradation of L5 and L5@LysSYL hydrogels was performed in PBS with pH 7.4 or 5.5 as previously described.[ 42 ] The hydrogel (500 µL) was prepared in a 5 mL injector, and the ready gel was gently injected into glass vials containing 10 mL PBS (pH 7.4 or 5.5). After the removal of the buffer, the gel was weighed. Then, 10 mL PBS was supplemented and the vials were incubated at 37 °C. At each determination time point, the supernatant was removed and the remaining gel was weighed. The weight loss of hydrogel samples was calculated. The experiment was repeated until the complete degradation of the hydrogels. The degradation assay was conducted in triplicates. Thermal Stability of L5@LysSYL Hydrogels The endolysin LysSYL (1 mg mL−1) and L5@LysSYL hydrogels were incubated at 80 °C for 10 min. Then 50 µL of LysSYL or L5@LysSYL was incubated with 200 µL of S. aureus XN108 suspension (5 × 107 CFU mL−1). The viable bacterial number was determined by colony counting. PBS served as a negative control and LysSYL at 4 °C served as a positive control. In Vitro Antimicrobial Activity of LysSYL‐Loaded Peptide Hydrogels MRSA strains USA300 and XN108 were cultured overnight and inoculated (1%, v/v) into fresh BHI media (pH 7.4 or 5.5). Subsequently, 90 µL of bacterial culture was added in a 96‐well plate with 10 µL of hydrogels formed previously. Then the plates were monitored immediately using a microplate reader (TECAN SPARK20 M, Switzerland) at 37 °C for 24 h. The bacterial culture without hydrogel treatment was used as the control. The antimicrobial activity of L5@LysSYL or L2@LysSYL hydrogels against S. aureus USA300 was assessed by CFU reduction assay. In brief, 200 µL of S. aureus USA300 suspension (5 × 107 CFU mL−1, pH 5.5) was introduced onto 50 µL of L5@LysSYL or L2@LysSYL hydrogels. After incubation, the viable bacterial number was determined by colony counting. RNA‐Seq Analysis S. aureus USA300 was cultivated to the mid‐log phase, centrifugated, washed, and diluted to 5 × 107 CFU mL−1 with PBS (pH 5.5). Then the bacterial suspension was incubated at 37 °C for 1 h in the presence of L5@LysSYL hydrogels. After incubation, total RNA was extracted using RNAprep Pure Cell/Bacteria Kit (TianGen, China). The quality and quantity of the total RNA were assessed by RNA‐seq Novogene Co., LTD (Beijing). The ribosomal RNA was eliminated by Ribo‐ZeroTM Gold Kit (Illumina) and the RNA‐seq libraries were prepared with Illumina TruSeq RNA Library Prep Kit. Then RNA sequencing was performed via Illumina HiSeq Novaseq‐PE150 sequencing system. Each group underwent three separate experiments. The DEGs were analyzed by DESeq2 package using a |fold‐change| > 1.5 and adjusted P‐value < 0.05. Mouse Wound Healing Assay The in vivo experiments were performed as previously described.[ 12 ] The BALB/c mice (female, 17–20 g) were adapted for 7 days and randomly divided into five groups, including PBS, LysSYL, L5, L5@LysSYL, and Mupirocin (purchased form Zhongmei Shike Pharmaceutical Co., Ltd., China). The mice were shaved, anesthetized, and a full‐thickness skin wound with a diameter of 10 mm was made on the back. Then 10 µL of S. aureus USA300 suspension (108 CFU) was added into the back and allowed to dry naturally. Next, the mouse wounds were fixed with Tegaderm (3M, USA) to avoid licking and scratching. After 48 h of infection, the wounds were treated with 100 µL of PBS, LysSYL (1 mg mL−1), L5 (10 mg mL−1), L5@LysSYL, and Mupirocin (20 mg g−1) twice a day for 7 days, followed by once daily for another week. During treatment, the wounds were photographed and measured on days 0, 3, 7, and 14. The wound healing rate was analyzed by Image J software. In addition, the wound tissues were collected and homogenized in PBS on days 7 and 14 for CFU counting. After 7 days of treatment, the wound tissues were collected for ELISA detection of cytokine levels (IL‐1β, TNF‐α, MCP‐1, and IL‐10) and RT‐qPCR determination of genes (vegf, egf, and fgf) using the relative kits (Thermo Fisher Scientific). On day 7 and 14, the wound tissues were collected, fixed with 4% (v/v) formalin, paraffin‐embedded, followed by hematoxylin and eosin (H&E), Masson, and immunohistochemistry staining. Safety Evaluation of L5@LysSYL Hydrogels The skin toxicity of L5@LysSYL hydrogels was evaluated as previously reported.[ 44 ] The back hairs of BALB/c mice (6–8 weeks) were shaved and the mice were randomly divided into five groups (n = 5 for each group). The mice were topically treated with 100 µL of PBS, 30% SDS, LysSYL, L5, and L5@LysSYL, respectively. After 24 h of treatment, the mice were sacrificed and their back skins were washed with PBS, obtained and subjected to H&E staining and analysis. Statistical Analysis All experiments were conducted in triplicate or/and repeated three times. The data were presented as mean ± standard deviation (SD). Sample size (n) for each statistical analysis was indicated in the Figure legends. GraphPad Prism 9.5 software was used, and the statistical analysis was performed by one‐way analysis of variance (ANOVA) or unpaired Student's t‐test. P < 0.05 was considered statistically significant. Ethics Approval Statement Female BALB/c mice (17–20 g, 6–8 weeks old) were purchased from the Vital River Laboratory Animal Technology Co. Ltd. (Beijing, China). All animal experiments were approved by the Laboratory Animal Welfare and Ethics Committee of Army Medical University (No. SYXK‐PLA‐20120031). Euthanasia of the experimental animals was performed by cervical dislocation. Conflict of Interest The authors declare no conflict of interest. Supporting information Supporting Information Acknowledgements S.L., W.S., and X.R. contributed equally to this work. This work was supported by the National Natural Science Foundations of China (Grant 82272341 to X.R.), the Natural Science Foundation of Chongqing (Grant CSTB2024NSCQ‐MSX0333 to S.L.), Chongqing Graduate Student Research Innovation Project (Grant CYB22274 to H.L.). The authors would like to thank all the members of the laboratories for helpful discussions. Liu H., Wei X., Peng H., Yang Y., Hu Z., Rao Y., Wang Z., Dou J., Huang X., Hu Q., Tan L., Wang Y., Chen J., Liu L., Yang Y., Wu J., Hu X., Lu S., Shang W., Rao X., LysSYL‐Loaded pH‐Switchable Self‐Assembling Peptide Hydrogels Promote Methicillin‐Resistant Staphylococcus Aureus Elimination and Wound Healing. Adv. Mater. 2024, 36, 2412154. 10.1002/adma.202412154 Contributor Information Shuguang Lu, Email: lusg@tmmu.edu.cn. Weilong Shang, Email: shangwl@tmmu.edu.cn. Xiancai Rao, Email: xcrao@tmmu.edu.cn. Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request. References Associated Data Supplementary Materials Supporting Information Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request.